An Observational Drug Utilization Study of SYCREST (Asenapine) in the United Kingdom
Phase of Trial: Phase IV
Latest Information Update: 10 Jan 2018
At a glance
- Drugs Asenapine (Primary) ; Amisulpride; Aripiprazole; Clozapine; Iloperidone; Lurasidone; Olanzapine; Paliperidone; Quetiapine; Risperidone; Sertindole; Ziprasidone; Zotepine
- Indications Bipolar disorders
- Focus Therapeutic Use
- Sponsors Merck & Co; Merck Sharp & Dohme
- 05 Jan 2018 Status changed from recruiting to completed.
- 09 Nov 2017 Planned End Date changed from 31 Oct 2017 to 18 Dec 2017.
- 09 Nov 2017 Planned primary completion date changed from 31 Oct 2017 to 18 Dec 2017.